Loratadine
Loratadine is a pharmaceutical drug with 36 clinical trials. Currently 4 active trials ongoing. Historical success rate of 85.2%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
13
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.2%
23 of 27 finished
14.8%
4 ended early
4
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Loratadine for the Prevention of G-CSF-related Bone Pain
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
Clinical Trials (36)
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Loratadine for the Prevention of G-CSF-related Bone Pain
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine
Combined Antihistaminics Therapy in COVID 19 Patients
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Gabapentin Versus Loratadine in Uremic Pruritus
Antihistamines in Eosinophilic Esophagitis
Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Effect of Loratadine in Lymphangioleiomyomatosis
A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis
Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 36